Cargando…

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases

Detalles Bibliográficos
Autores principales:	Felten, Renaud, Dubois, Maxime, Ugarte-Gil, Manuel F, Chaudier, Aurore, Kawka, Lou, Bergier, Hugo, Costecalde, Charlotte, Pijnenburg, Luc, Fort, Jérémy, Chatelus, Emmanuel, Sordet, Christelle, Javier, Rose-Marie, Gottenberg, Jacques-Eric, Sibilia, Jean, Fuentes-Silva, Yurilis, Arnaud, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906671/ https://www.ncbi.nlm.nih.gov/pubmed/33655219 http://dx.doi.org/10.1016/S2665-9913(21)00039-4

Ejemplares similares

Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study
por: Felten, Renaud, et al.
Publicado: (2021)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study
por: Scherlinger, Marc, et al.
Publicado: (2021)

Évolution de l’immunité cellulaire et humorale anti-SARS-CoV-2 après 3 doses de vaccins chez des patients traités par rituximab
por: Felten, R., et al.
Publicado: (2021)

Effet de la vaccination anti-SARS-CoV-2 sur les symptômes prolongés post-Covid : résultat de l’enquête nationale VAXILONG
por: Scherlinger, M., et al.
Publicado: (2021)

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France
por: Felten, Renaud, et al.
Publicado: (2021)

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
por: Felten, Renaud, et al.
Publicado: (2022)

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries
por: El Kibbi, Lina, et al.
Publicado: (2022)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren’s syndrome
por: Kawka, Lou, et al.
Publicado: (2023)

Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry
por: Seror, Raphaèle, et al.
Publicado: (2022)

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage
por: Blaess, Julien, et al.
Publicado: (2020)

How and why are rheumatologists relevant to COVID-19?
por: Felten, Renaud, et al.
Publicado: (2020)

Comment et pourquoi les rhumatologues sont importants face à la crise du COVID-19 ?()
por: Felten, Renaud, et al.
Publicado: (2020)

Importance of nociplastic pain in patients with rheumatic diseases
por: Alcántara Montero, Antonio
Publicado: (2023)

Life expectancy, healthy life expectancy, and inequalities in Hong Kong, 2007–2020
por: Minton, Jon, et al.
Publicado: (2023)

Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection
por: Scherlinger, Marc, et al.
Publicado: (2021)

Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis
por: Alsaleh, Ghada, et al.
Publicado: (2010)

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
por: François, Antoine, et al.
Publicado: (2013)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

COVID-19 in patients with rheumatic disease: finally, a denominator
por: Wallace, Daniel J
Publicado: (2021)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

SARS legacy: outbreak reporting is expected and respected
por: Heymann, David L, et al.
Publicado: (2013)

Nutrition-related health taxes: setting expectations
por: Miranda, J Jaime, et al.
Publicado: (2022)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Canada 2010: what should global health expect?
por: Horton, Richard
Publicado: (2009)

COVID-19 and strongyloidiasis: what to expect from this coinfection?
por: Pereira, Carolina Victoria Marcitelli, et al.
Publicado: (2021)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

Offline: COVID-19—what we can expect to come
por: Horton, Richard
Publicado: (2020)

The COVID-19 pandemic in the USA: what might we expect?
por: Chowell, Gerardo, et al.
Publicado: (2020)

First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea
por: Schreiber, Karen, et al.
Publicado: (2021)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2006)

Coordination régionale et suivi prospectif du traitement prophylactique et curatif de 301 patients traités par anticorps monoclonaux anti-SARS-CoV-2
por: Licinio, P., et al.
Publicado: (2022)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
por: Widawski, L., et al.
Publicado: (2022)

What can we expect from first-generation COVID-19 vaccines?
por: Peiris, Malik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4r4t8lkd0u8tt0ho78222kvgt7